Radical Treatment

2020 ◽  
Author(s):  
RICHARD LEBLANC
Keyword(s):  
1987 ◽  
Vol 14 (1) ◽  
pp. 101-111 ◽  
Author(s):  
Wolfgang Mühlbauer ◽  
Hans Anderl ◽  
Peter Ramatschi ◽  
Peter Heeckt ◽  
Cand Med ◽  
...  

1911 ◽  
Vol 4 (Obstet_Gynaecol) ◽  
pp. 264-270
Author(s):  
Ernest W. Hey Groves
Keyword(s):  

2020 ◽  
pp. 205141582098277
Author(s):  
Thomas Thompson ◽  
Thomas Brophy ◽  
Mohsin Uddin ◽  
James Bolton ◽  
Richard Napier-Hemy

2020 ◽  
Vol 152 ◽  
pp. S579-S580
Author(s):  
M. Kraszkiewicz ◽  
A. Napieralska ◽  
L. Miszczyk ◽  
W. Majewski

Author(s):  
Leonardo Muratori ◽  
Paola Sperone ◽  
Gabriella Gorzegno ◽  
Anna La Salvia ◽  
Giorgio Vittorio Scagliotti

Abstract Background Endometrial carcinoma is one of the most common female cancers in developed countries. Disease stage is associated with the risk of disease relapse after radical treatment. Typically, the risk of disease relapse peaks at 3 years from local radical treatment and then diminishes over time, so that late relapses (i.e., from year 5 afterward) are extremely infrequent. Here, we report two cases of women with endometrial cancer who developed a disease relapse more than 15 years after radical treatment. A review of the literature revealed other seven reports of women with relapse from endometrial cancer occurring more than 10 years after radical treatment. Case presentation Case report 1 is a 56-year-old woman with an endometrioid cancer who underwent a hysterectomy with bilateral salpingo-oophorectomy in 1998. She relapsed in the lung in 2014, 16 years from radical surgery. Case report 2, a 75-year-old woman, with an endometrioid cancer, was treated by hysterectomy with bilateral salpingo-oophorectomy and adjuvant radiotherapy. The disease relapse in the lung was detected in 2019, 22 years from radical treatment. Conclusion Although guidelines do not support oncological follow-up beyond 5 years from surgery, oncologists should consider late recurrence of endometrial carcinoma in the differential diagnosis of women presenting with metastases of uncertain origin and prior history of this disease.


Sign in / Sign up

Export Citation Format

Share Document